Author:
Bhaw-Luximon Archana,Jhurry Dhanjay
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference117 articles.
1. Ahlin G, Chen L, Lazorova L et al (2011) Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions. Pharmacogenomics J 11(6):400–411. doi: 10.1038/tpj.2010.54
2. Algire C, Amrein L, Bazile M, David S, Zakikhani M, Pollak M (2011) Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo. Oncogene 30:1174–1182
3. Alvarez R, Musteanu M, Garcia-Garcia E et al (2013) Stromal disrupting effects of nab-paclitaxel in pancreatic cancer. Br J Cancer 109:926–933
4. Ambe CM, Mahipal A, Fulp J, Chen L, Malafa MP (2016) Effect of metformin use on survival in resectable pancreatic cancer: a single-institution experience and review of the literature. PLoS ONE 11(3):e0151632. doi: 10.1371/journal.pone.0151632
5. Amgen (2012) Amgen announces termination of ganitumab phase 3 study for futility. In: Metastatic pancreatic cancer. http://www.prnewswire.com/news-releases/amgen-announces-termination-of-ganitumab-phase-3-study-for-futility-in-metastatic-pancreatic-cancer-165476446.html . Accessed 2 Apr 2016
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献